Cytokine-induced sickness behavior

被引:0
|
作者
Kelley, KW
Bluthé, RM
Dantzer, R
Zhou, JH
Shen, WH
Johnson, RW
Broussard, SR
机构
[1] Univ Illinois, Dept Anim Sci, Immunophysiol Lab, Urbana, IL 61801 USA
[2] Inst Francois Magendie, INSERM, INRA, U394,Unite Rech Neurobiol Integrat, F-33077 Bordeaux, France
[3] Univ Illinois, Dept Anim Sci, Lab Integrat Biol, Anim Sci Lab 390, Urbana, IL 61801 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The behavioral repertoire of humans and animals changes dramatically following infection. Sick individuals have little motivation to eat, are listless, complain of fatigue and malaise, loose interest in social activities and have significant changes in sleep patterns. They display an inability to experience pleasure, have exaggerated responses to pain and fail to concentrate. Proinflammatory cytokines acting in the brain cause sickness behaviors. These nearly universal behavioral changes are a manifestation of a central motivational state that is designed to promote recovery. Exaggerated symptoms of sickness in cancer patients, such as cachexia, can be life-threatening. However, quality of life is often drastically impaired before the cancer becomes totally debilitating. Although basic studies in psychoneuroimmunology have defined proinflammatory cytokines as the central mediators of sickness behavior, a much better understanding of how cytokine and neurotransmitter receptors communicate with each other is needed. Advances that have been made during the past decade should now be extended to clinical studies in an attempt to alleviate sickness symptoms and improve quality of life for cancer patients. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:S112 / S118
页数:7
相关论文
共 50 条
  • [31] NEMO integrates cytokine-induced osteoclastogenesis.
    Abu-Amer, Y
    Dai, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S84 - S84
  • [32] Antidepressant treatment of cytokine-induced mood disorders
    Raison, CL
    Marcin, M
    Miller, AH
    ACTA NEUROPSYCHIATRICA, 2002, 14 (06): : 336 - 343
  • [33] Cancer Immunotherapy with Cytokine-Induced Killer Cells
    Juan J. Mata-Molanes
    Manuel Sureda González
    Belén Valenzuela Jiménez
    Elena Mª Martínez Navarro
    Antonio Brugarolas Masllorens
    Targeted Oncology, 2017, 12 : 289 - 299
  • [34] POTENTIATION OF CYTOKINE-INDUCED INFLAMMATION BY OXIDIZED PHOSPHOLIPIDS
    Hodzic, Alma
    Gesslbauer, Bernd
    Bochkov, Valery
    Oskolkova, Olga
    FREE RADICAL BIOLOGY AND MEDICINE, 2023, 201 : 27 - 28
  • [35] Cytokine-induced calgranulin C expression in keratocytes
    Gottsch, JD
    Li, Q
    Ashraf, F
    O'Brien, TP
    Stark, WJ
    Liu, SH
    CLINICAL IMMUNOLOGY, 1999, 91 (01) : 34 - 40
  • [36] The role of cytokine-induced neutrophil chemoattractant in ovulation
    Tanaka, Y
    Miura, N
    Ogata, R
    Uemura, H
    Kuwahara, A
    Saito, S
    Ikawa, H
    Yasui, T
    Irahara, M
    Aono, T
    IFFS 2001 SELECTED FREE COMMUNICATIONS, 2001, : 319 - 323
  • [37] Cytokine-induced ECM alterations in DR pathogenesis
    Giblin, Meredith
    Penn, John S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [38] Cancer Immunotherapy with Cytokine-Induced Killer Cells
    Mata-Molanes, Juan J.
    Sureda Gonzalez, Manuel
    Valenzuela Jimenez, Belen
    Martinez Navarro, Elena Ma
    Brugarolas Masllorens, Antonio
    TARGETED ONCOLOGY, 2017, 12 (03) : 289 - 299
  • [39] In search of animal models of cytokine-induced depression
    De La Garza, Richard, II
    Asnis, Gregory M.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (07): : 1366 - 1366
  • [40] Mechanism involved in cytokine-induced cholestasis.
    Hillaire, S
    REVUE DE MEDECINE INTERNE, 2000, 21 (05): : 467 - 469